Eczema.Dupixent is used for eczema (atopic dermatitis) that is moderate to severe in adults and children 6 months and older whose condition is not well controlled with prescription treatments used on the skin (topical) or who cannot use topical therapies. Dupixent for eczema can be used with ...
DUPIXENT is a prescription medicine used to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be use...
Dupixent (dupilumab) is an injection that treats atopic dermatitis (eczema) for people whose condition doesn't respond to prescription eczema creams and ointments. Dupixent can be used with or without topical corticosteroids. Inflammation and allergic reaction are side effects of Dupixent, among others...
to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical...
to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical...
patient living with moderate-to-severe eczema. Individual results may vary. DUPIXENT results in adults Filter by:Clear All Filters Age Young Children (6 months to 5 years)Child (6-11 years)Teen (12-17 years)Adult (18+ years) Topics ...
Dupilumab also wasapproved in the United Statesin March this year for use in adults with moderate to severe atopic dermatitis (a form of eczema) that is poorly controlled with prescription topical treatments or those who cannot use topical treatments. ...
In children 6 to 11 years old using Dupixent plus a topical corticosteroid (TCS) for severe eczema, who received either the 200 mg or 300 mg dose, over twice as many children saw clear or almost clear skin at 16 weeks when compared to those using a topical corticosteroid only. ...
Dupixent (dupilumab) injection is aninterleukin-4 receptor alpha-antagonist indicated for the treatment of patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable; as an add-on maintenance ...
to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical cortic...